Most oncology clinical trials that assess quality of life do so only during or shortly after the treatment or intervention rather than continuing after disease progression or until death, according to results of a cross-sectional analysis published in JAMA Network Open.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.